222 related articles for article (PubMed ID: 9584331)
1. Sustained cholecystokinin-B/gastrin receptor blockade does not impair basal or histamine-stimulated acid secretion in chronic gastric fistula rats.
Ding XQ; Kitano M; Håkanson R
Pharmacol Toxicol; 1998 Apr; 82(4):177-82. PubMed ID: 9584331
[TBL] [Abstract][Full Text] [Related]
2. Effect of cholecystokinin-B/gastrin receptor blockade on gastric acid secretion in conscious rats.
Ding XQ; Håkanson R
Pharmacol Toxicol; 1996 Dec; 79(6):324-30. PubMed ID: 9000260
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin-B/gastrin receptor blockade suppresses the activity of rat stomach ECL cells.
Ding XQ; Lindström E; Håkanson R
Pharmacol Toxicol; 1997 Jul; 81(1):19-25. PubMed ID: 9258980
[TBL] [Abstract][Full Text] [Related]
4. Time-course of deactivation of rat stomach ECL cells following cholecystokinin B/gastrin receptor blockade.
Ding XQ; Lindström E; Håkanson R
Br J Pharmacol; 1997 Sep; 122(1):1-6. PubMed ID: 9298521
[TBL] [Abstract][Full Text] [Related]
5. CCK2 receptor antagonists: pharmacological tools to study the gastrin-ECL cell-parietal cell axis.
Håkanson R; Ding XQ; Norlén P; Lindström E
Regul Pept; 1999 Mar; 80(1-2):1-12. PubMed ID: 10235629
[TBL] [Abstract][Full Text] [Related]
6. YM022, a highly potent and selective CCKB antagonist inhibiting gastric acid secretion in the rat, the cat and isolated rabbit glands.
Attoub S; Moizo L; Laigneau JP; Alchepo B; Lewin MJ; Bado A
Fundam Clin Pharmacol; 1998; 12(3):256-62. PubMed ID: 9646057
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of cholecystokinin-B/gastrin receptor blockade: a study of the gastrin-ECL cell axis in the rat.
Norlén P; Lindström E; Ding XQ; Kitano M; Håkanson R
Pharmacol Toxicol; 1999 Apr; 84(4):159-64. PubMed ID: 10227066
[TBL] [Abstract][Full Text] [Related]
8. Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.
Kitano M; Norlén P; Ding XQ; Nakamura S; Håkanson R
Br J Pharmacol; 2000 Jun; 130(3):699-705. PubMed ID: 10821801
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of the role of endogenous gastrin in basal acid secretion in conscious rats provided with chronic fistula and pylorus ligation.
Nishida A; Uchida-Kobayashi A; Takemoto Y; Akuzawa S; Miyata K
Jpn J Pharmacol; 1996 Jul; 71(3):223-30. PubMed ID: 8854204
[TBL] [Abstract][Full Text] [Related]
10. YM022, a potent and selective gastrin/CCK-B receptor antagonist, inhibits peptone meal-induced gastric acid secretion in Heidenhain pouch dogs.
Yuki H; Nishida A; Miyake A; Ito H; Akuzawa S; Takinami Y; Takemoto Y; Miyata K
Dig Dis Sci; 1997 Apr; 42(4):707-14. PubMed ID: 9125636
[TBL] [Abstract][Full Text] [Related]
11. Effect of cholecystokinin-2 receptor blockade on rat stomach ECL cells. A histochemical, electron-microscopic and chemical study.
Chen D; Zhao CM; Norlén P; Björkqvist M; Ding XQ; Kitano M; Håkanson R
Cell Tissue Res; 2000 Jan; 299(1):81-95. PubMed ID: 10654072
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the specificity and potency of a series of cholecystokinin-B/gastrin receptor antagonists in vivo.
Ding XQ; Håkanson R
Pharmacol Toxicol; 1996 Sep; 79(3):124-30. PubMed ID: 8884870
[TBL] [Abstract][Full Text] [Related]
13. Gastrin receptor antagonist YM022 prevents hypersecretion after long-term acid suppression.
Nishida A; Kobayashi-Uchida A; Akuzawa S; Takinami Y; Shishido T; Kamato T; Ito H; Yamano M; Yuki H; Nagakura Y
Am J Physiol; 1995 Nov; 269(5 Pt 1):G699-705. PubMed ID: 7491961
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of three novel cholecystokinin-B/gastrin receptor antagonists: a study of their effects on rat stomach enterochromaffin-like cell activity.
Ding XQ; Lindström E; Håkanson R
Pharmacol Toxicol; 1997 Nov; 81(5):232-7. PubMed ID: 9396089
[TBL] [Abstract][Full Text] [Related]
15. Anaesthetic agents inhibit gastrin-stimulated but not basal histamine release from rat stomach ECL cells.
Norlén P; Kitano M; Lindström E; Håkanson R
Br J Pharmacol; 2000 Jun; 130(4):725-30. PubMed ID: 10864877
[TBL] [Abstract][Full Text] [Related]
16. Role of gastrin/CCK-B receptor in the regulation of gastric acid secretion in rat.
Tari A; Kamiyasu T; Yonei Y; Hamada M; Sumii M; Sumii K; Kajiyama G; Dimaline R
Dig Dis Sci; 1997 Sep; 42(9):1901-7. PubMed ID: 9331153
[TBL] [Abstract][Full Text] [Related]
17. Mobilization of rat stomach ECL-cell histamine in response to short- or long-term treatment with omeprazole and/or YF 476 studied by gastric submucosal microdialysis in conscious rats.
Konagaya T; Bernsand M; Norlén P; Håkanson R
Br J Pharmacol; 2001 May; 133(1):37-42. PubMed ID: 11325792
[TBL] [Abstract][Full Text] [Related]
18. Role of gastrin and cholecystokinin receptors in regulation of peptone-stimulated gastric acid secretion in conscious rats.
Varga G; Campbell DR; Bussjaeger LJ; Solomon TE
Eur J Pharmacol; 1993 Nov; 250(1):37-42. PubMed ID: 8119323
[TBL] [Abstract][Full Text] [Related]
19. Gastric acid secretion after depletion of enterochromaffin-like cell histamine. A study with alpha-fluoromethylhistidine in rats.
Andersson K; Cabero JL; Mattsson H; Håkanson R
Scand J Gastroenterol; 1996 Jan; 31(1):24-30. PubMed ID: 8927936
[TBL] [Abstract][Full Text] [Related]
20. Biological activity of analogues of YM022. Novel (3-amino substituted phenyl)urea derivatives of 1,4-benzodiazepin-2-one as gastrin/cholecystokinin-B receptor antagonists.
Satoh M; Okamoto Y; Koshio H; Ohta M; Nishida A; Akuzawa S; Miyata K; Mase T; Semple G
Chem Pharm Bull (Tokyo); 1996 Jul; 44(7):1412-4. PubMed ID: 8706146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
